Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,134 recalls, newest first

Class II · Moderate risk

NitroGlycerin

Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.

Terminated Stability / shelf life Advanced Pharma Inc. NDC 15082-863-61 D-0119-2018
Class II · Moderate risk

NitroGlycerin

Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.

Terminated Stability / shelf life Advanced Pharma Inc. NDC 15082-863-67 D-0118-2018
Class I · High risk

NitroGlycerin

Subpotent Drug: found to be below the specification for labeled assay.

Terminated Wrong potency / content Advanced Pharma Inc. NDC 15082-863-61 D-0115-2018
Class I · High risk

NitroGlycerin

Subpotent Drug: found to be below the specification for labeled assay.

Terminated Wrong potency / content Advanced Pharma Inc. NDC 15082-863-67 D-0114-2018
Class II · Moderate risk

VenomX

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Terminated Stability / shelf life Phillips Co. NDC 43074-207-01 D-0952-2017
Class II · Moderate risk

StaphWash+Plus+ Skin Protectant

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Terminated Stability / shelf life Phillips Co. NDC 43074-101-01 D-0951-2017
Class II · Moderate risk

StingMed Insect bites Skin Protectant. Zinc acetate

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Terminated Stability / shelf life Phillips Co. NDC 04307-100-11 D-0950-2017
Class I · High risk

Andropharm M1 Alpha

Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.

Terminated Unapproved drug Andropharm, LLC D-1143-2017
Class I · High risk

Andropharm Sten Z

Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.

Terminated Unapproved drug Andropharm, LLC D-1142-2017
Class II · Moderate risk

NasalCrom (cromolyn sodium)

CGMP Deviations: Possibility of the presence of microbial contamination in the water used to manufacture this product lot.

Terminated Microbial contamination Bausch & Lomb, Inc. D-0899-2017
Class I · High risk

EliquisTablets 5mg

Labeling: Label Mix-up: One bottle of Eliquis 5 mg tablet was found to contain lower-strength Eliquis 2.5 mg tablets only instead of the labeled 5 mg tablets.

Terminated Labeling / mix-up Bristol-myers Squibb Company NDC 0003-0894-21 D-0959-2017

Recalls by year